Dr. Satya Prakash Yadav

Qualification - MBBS, DCH, DNB

Specialization - Hematologist

Designation - Director

Location - New Delhi, India

Hospital(s) - Medanta The Medicity

Clinical Focus - Paediatric Blood disorders, Paediatric Oncology, Bone Marrow Transplant

  |  0 recommendation(s)

Your Inquiry

Inquire for Bone Marrow Transplant (BMT) from Dr. Satya Prakash Yadav

Please select a Procedure from the above list. Help

Number of Days in Hospital: Select Procedure

Number of Trips Needed: Select Procedure

from $ 0000

Career Profile

Dr. Satya Yadav treats children with blood and cancer disorders at Medanta Hospital, Gurgaon, India. His clinical focus is primarily Paediatric Leukemia and blood & marrow transplantation. He has a goal to make BMT available and affordable to all those who need it. After finishing his training in Paediatrics from Delhi, he went to Sydney, Australia, and worked as a fellow (2002-2005) in Paediatric Hemato-Oncology at The Children’s Hospital at Westmead.

He has an experience of over 15 years and has performed more than 400 blood &marrow transplants including 50 unrelated donor/cord transplants and 50 Haplo identical Bone marrow transplants. He has published in various national and international journals with nearly 500 citations. He was a teaching faculty for fellowship of National Board of Examinations (FNB) in Paediatric Hematology Oncology at Sir Ganga Ram Hospital for 6 years. He has trained nearly 20 fellows in paediatric hematology oncology who are working as consultants within and outside India.

Clinical Focus

  • Paediatric Blood disorders
  • Paediatric Oncology
  • Bone Marrow Transplant

Awards & Achievements

  • Dr CK Bhalla Award 2002 Best Senior Resident in Pediatrics

Research and Publications

  • Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukemia- "British Journal Of Hematology" in 2006
  • Population pharmacokinetics of liposomal amphotericin B in paediatric patients with malignant diseases- "Antimicrob Agents Chemother" in 2006
  • Human heme oxygenase-1 deficiency presenting with hemolysis, nephritis, and asplenia- "J Pediatr Hematol Oncol" in 2011
  • Persistence of both cords nine months post double cord blood transplantation for juvenile myelomonocytic leukaemia - "Hematol Oncol Stem Cell Therapy" in 2013.
  • Paediatric Allogeneic Stem Cell Transplantation: Experience from the Developing World - "Pediatr Hematol Oncol." in 2013
  • Primary Immunodeficiency Disorders in the Developing World: Data from a Hospital-Based Registry in India - "Pediatr Hematol Oncol." In 2013
  • Successful treatment of Trichosporon asahii infection with voriconazole after bone marrow transplant - "J Pediatr Hematol Oncol" in 2013
  • Outcome of Paediatric Acquired Aplastic Anemia: A Developing World Experience - "Pediatr Hematol Oncol." In 2013
  • Hemophagocytic Lymphohistiocytosis in Infants: A Single Center Experience from India - "Pediatr Hematol Oncol." In 2014
  • Barriers to cure for children with cancer in India and strategies to improve outcomes: a report by the Indian pediatric hematology oncology group - "Pediatr Hematol Oncol." In 2014
  • Management of childhood brain tumors: consensus report by the Pediatric Hematology Oncology (PHO) Chapter of Indian Academy of Paediatrics (IAP) - "Indian J Pediatr" in 2011


  • American Society of Hematology (ASH)
  • American Society of Clinical Oncology (ASCO)
  • International Society of Pediatric Oncology (SIOP)
  • Pediatric Hemato-Oncology (PHO) Chapter of Indian Academy of Pediatrics (IAP)



Dr. Yadav performs 25 different procedures. Click on a procedure name to see more details and to view doctors for that specialty.


Bone Marrow Transplant (also known as stem cell transplant) uses transplanted bone marrow and/or stem cells to replace the diseased bone marrow of the patient. Therefore, people that undergo this treatment usually have leukemia, lymphoma, or other similar conditions. The replacement bone marrow or stem cells can come either from the patient themselves (autologous transplantation) or from another donor (allogeneic transplantation). In order to transplant the new healthy cells, the old cells are first destroyed using chemotherapy; then, the new cells can be implanted.

Autologous Bone Marrow Transplant

Please Inquire

Allogenic Bone Marrow Transplant

Please Inquire

Aplastic Anemia

Please Inquire

Pediatric Bone Marrow Transplant

Please Inquire

Thalassemia Transplant

Please Inquire

Fanconi Anemia

Please Inquire

Multiple Sclerosis

Please Inquire

Lymphoma Treatment

Please Inquire

Leukemia Treatment

Please Inquire

Myeloma Treatment

Please Inquire



Please Inquire


Please Inquire

Fractionated Stereotactic Radiation Therapy

Please Inquire


Please Inquire

Image-guided radiation therapy (IGRT)

Please Inquire

Intensity modulated radiation therapy (IMRT)

Please Inquire

Rapid Arc with IGRT

Please Inquire

Rapid Arc with IMRT

Please Inquire

Stereotactic Radiosurgery (SRS) Novalis Tx Frameless

Please Inquire

Stereotactic Radiotherapy (SRS) Novalis Tx with Frame

Please Inquire

Skull Base Surgery

Please Inquire

Cyberknife for Prostate Cancer

Please Inquire

HIFU (High Intensity Focused Ultrasound) for prostate cancer

Please Inquire

Rapid Arc with IGRT for prostate cancer

Please Inquire

Rapid Arc with IMRT for prostate cancer

Please Inquire

Green Light Laser PVP Surgery

Please Inquire

Brachytherapy for prostate cancer

Please Inquire

General Inquiry


Provider Knowledge
Procedure skills
Waiting & Exam Rooms
After care follow-up

Help us improve this Page

4.2 average based on 50 reviews.